In a significant advancement, Russia has developed an mRNA-based vaccine targeting cancer, according to reports from the national news agency TASS. The vaccine is slated to be available to patients at no cost by 2025. Collaborative Effort and Development Andrey Kaprin, General Director of the Radiology Medical Research Centre under …
Read More »